HC Bars Cipla, 3 others from launching generic version of Bristol-Myers’ drug
Posted by
www.biotecnika.org
Delhi High Court has granted an injunction restraining the domestic
pharma companies such as Cipla, Torrent, Emcure, Alkem from selling a
medicine used for prevention and treatment of thromboembolic diseases,
the patent for which is held by Bristol-Myers Squibb (BMS) as it filed
its claims for patent infringement of Apixaban in Delhi HC.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hc-bars-cipla-3-others-from-launching-generic-version-of-bristol-myers-drug/articleshow/73183597.cms
Subscribe to:
Post Comments (Atom)
Post a Comment